Suggestions
Keith McCullagh
Chairman at Metrion Biosciences Ltd
Keith McCullagh PhD
Non-Executive Chairman of Metrion Biosciences
Keith McCullagh is an experienced pharmaceutical research & development executive and bioscience entrepreneur. He was a co-founder of Metrion Biosciences and currently serves as the Non-Executive Chairman of the company's Board of Directors.12
McCullagh has extensive experience in the bioscience industry. He previously served as Chairman of several other companies, including Xention, Ario Pharma, Affitech, Pharmacy 2U and Clavis Pharma.1 He was also the Chief Executive of Santaris Pharma, an RNA medicines company sold to Roche in 2014.1
From 1986 to 1998, McCullagh was Chief Executive of British Biotech, now Vernalis (a subsidiary of Hitgen), a company he founded and built into one of Europe's first public biopharmaceutical businesses.1 Prior to British Biotech, he was UK Research Director for GD Searle & Co, Inc., now part of Pfizer.1
McCullagh holds a degree in Veterinary Medicine from the University of Bristol and a PhD in Pathology from the University of Cambridge.13 His LinkedIn username is keith-mccullagh.3
